Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

The Fruits of Paris polyphylla Inhibit Colorectal Cancer Cell Migration Induced by Fusobacterium nucleatum -Derived Extracellular Vesicles.

Tytuł:
The Fruits of Paris polyphylla Inhibit Colorectal Cancer Cell Migration Induced by Fusobacterium nucleatum -Derived Extracellular Vesicles.
Autorzy:
Lin LT; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Shi YC; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Choong CY; Department of Chinese Medicine, Taipei University Hospital, Taipei 110301, Taiwan.
Tai CJ; Department of Chinese Medicine, Taipei University Hospital, Taipei 110301, Taiwan.; Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei 110301, Taiwan.; Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2021 Jul 04; Vol. 26 (13). Date of Electronic Publication: 2021 Jul 04.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, c1995-
MeSH Terms:
Cell Movement*
Colorectal Neoplasms/*drug therapy
Extracellular Vesicles/*microbiology
Fruit/*chemistry
Fusobacterium nucleatum/*physiology
Liliaceae/*chemistry
Plant Extracts/*pharmacology
Carcinogenesis ; Cell Proliferation ; Colorectal Neoplasms/microbiology ; Colorectal Neoplasms/pathology ; Humans ; Tumor Cells, Cultured
References:
Nat Commun. 2015 Oct 30;6:8727. (PMID: 26515465)
Sci Rep. 2015 Nov 13;5:16643. (PMID: 26563823)
Molecules. 2016 Jun 03;21(6):. (PMID: 27271583)
ACS Omega. 2018 Sep 30;3(9):10927-10937. (PMID: 30288460)
mBio. 2021 Mar 2;12(2):. (PMID: 33653893)
Molecules. 2013 Oct 17;18(10):12916-36. (PMID: 24141243)
Int J Obes (Lond). 2015 Dec;39(12):1750-6. (PMID: 26119995)
Sci Signal. 2020 Jul 21;13(641):. (PMID: 32694172)
Onco Targets Ther. 2017 Oct 17;10:5031-5046. (PMID: 29081665)
Probiotics Antimicrob Proteins. 2019 Dec;11(4):1155-1162. (PMID: 30311185)
Biochem Pharmacol. 2014 Mar 15;88(2):150-7. (PMID: 24462916)
Cell Host Microbe. 2013 Aug 14;14(2):195-206. (PMID: 23954158)
Gastroenterology. 2017 Dec;153(6):1621-1633.e6. (PMID: 28823860)
Microbiol Spectr. 2017 Jun;5(3):. (PMID: 28643625)
EMBO J. 2008 Jan 23;27(2):433-46. (PMID: 18200046)
Asian Pac J Cancer Prev. 2014;15(24):10911-6. (PMID: 25605200)
Gut. 2017 Aug;66(8):1441-1448. (PMID: 27797940)
Sci Rep. 2015 Oct 29;5:15878. (PMID: 26510393)
Food Chem. 2021 Mar 15;340:128104. (PMID: 33010644)
Autophagy. 2011 Oct;7(10):1251-3. (PMID: 21743300)
Genome Res. 2012 Feb;22(2):299-306. (PMID: 22009989)
Mol Biol Cell. 2004 Nov;15(11):5001-11. (PMID: 15356267)
Cancer Lett. 2016 Sep 28;380(1):356-8. (PMID: 26739062)
Science. 2017 Dec 15;358(6369):1443-1448. (PMID: 29170280)
Nat Commun. 2017 Sep 20;8(1):626. (PMID: 28931823)
Gut Microbes. 2021 Jan-Dec;13(1):1-20. (PMID: 33769187)
Phytother Res. 2012 Oct;26(10):1449-65. (PMID: 22389143)
Front Immunol. 2020 Dec 21;11:583644. (PMID: 33408714)
BMC Complement Altern Med. 2016 Feb 09;16:58. (PMID: 26861252)
ISME J. 2012 Feb;6(2):320-9. (PMID: 21850056)
Nat Commun. 2015 Apr 24;6:6956. (PMID: 25907800)
PLoS One. 2011;6(11):e27958. (PMID: 22114730)
Exp Mol Med. 2016 Feb 05;48:e208. (PMID: 26846451)
Plant Signal Behav. 2009 May;4(5):413-5. (PMID: 19816118)
Asian Pac J Cancer Prev. 2012;13(1):205-9. (PMID: 22502669)
Oncotarget. 2015 Oct 13;6(31):32013-26. (PMID: 26397137)
Cell Host Microbe. 2013 Aug 14;14(2):207-15. (PMID: 23954159)
Nat Prod Bioprospect. 2018 Aug;8(4):265-278. (PMID: 29974350)
Cell. 2017 Jul 27;170(3):548-563.e16. (PMID: 28753429)
Science. 2018 Jan 5;359(6371):91-97. (PMID: 29097494)
Molecules. 2019 Jun 03;24(11):. (PMID: 31163662)
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. (PMID: 23671105)
Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):358-363. (PMID: 31749925)
Contributed Indexing:
Keywords: Fusobacterium nucleatum; Paris polyphylla; cell migration; complementary medicine; extracellular vesicles
Substance Nomenclature:
0 (Plant Extracts)
Entry Date(s):
Date Created: 20210719 Date Completed: 20210913 Latest Revision: 20210913
Update Code:
20240105
PubMed Central ID:
PMC8271733
DOI:
10.3390/molecules26134081
PMID:
34279421
Czasopismo naukowe
Colorectal cancer (CRC) is one of the most common cancers worldwide. Gut microbiota are highly associated with CRC, and Fusobacterium nucleatum was found to be enriched in CRC lesions and correlated with CRC carcinogenesis and metastases. Paris polyphylla is a well-known herbal medicine that showed anticancer activity. The present study demonstrates that P. polyphylla inhibited the growth of CRC cells. In addition, treating with active compounds pennogenin 3- O -beta-chacotrioside and polyphyllin VI isolated from P. polyphylla inhibited the growth of F. nucleatum . We also found that extracellular vesicles (EVs) released from F. nucleatum could promote mitochondrial fusion and cell invasion in CRC cells, whereas active components from P. polyphylla could dampen such an impact. The data suggest that P. polyphylla and its active ingredients could be further explored as potential candidates for developing complementary chemotherapy for the treatment of CRC.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies